Literature DB >> 23255396

Genome guardian p53 and viral infections.

Yoshitaka Sato1, Tatsuya Tsurumi.   

Abstract

Because virus infections elicit various cellular responses that inhibit viral replication and growth, viruses must intervene to attenuate antiviral measures in order to thrive. The genome guardian p53 plays a central part not only in DNA damage responses, inducing cell cycle arrest or apoptosis, but also in the innate host immune control of viral infections by orchestrating diverse signaling pathways originating from many different cellular receptors and sensors. Many viruses have acquired sophisticated mechanisms to regulate p53 functions by deploying subversive proteins and modulating its post-transcriptional status. In this review, we overview the mechanisms by which DNA and RNA viruses manage p53 signaling in favor of their continued survival.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23255396     DOI: 10.1002/rmv.1738

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  41 in total

1.  Genus beta human papillomavirus E6 proteins vary in their effects on the transactivation of p53 target genes.

Authors:  Elizabeth A White; Johanna Walther; Hassan Javanbakht; Peter M Howley
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

2.  Lysine-specific post-translational modifications of proteins in the life cycle of viruses.

Authors:  Anna P Loboda; Surinder M Soond; Mauro Piacentini; Nickolai A Barlev
Journal:  Cell Cycle       Date:  2019-07-10       Impact factor: 4.534

Review 3.  Attenuating the p53 Pathway in Human Cancers: Many Means to the Same End.

Authors:  Amanda R Wasylishen; Guillermina Lozano
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

4.  Murine Cytomegalovirus M25 Proteins Sequester the Tumor Suppressor Protein p53 in Nuclear Accumulations.

Authors:  Martina Dezeljin; Martin Messerle; Ivana Kutle; Katarzyna M Szymańska-de Wijs; Boris Bogdanow; Berislav Cuvalo; Lars Steinbrück; Stipan Jonjić; Karen Wagner; Rainer Niedenthal; Matthias Selbach; Lüder Wiebusch
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

5.  An unexpected inhibition of antiviral signaling by virus-encoded tumor suppressor p53 in pancreatic cancer cells.

Authors:  Eric Hastie; Marcela Cataldi; Nury Steuerwald; Valery Z Grdzelishvili
Journal:  Virology       Date:  2015-05-15       Impact factor: 3.616

6.  The Nonstructural NS1 Protein of Influenza Viruses Modulates TP53 Splicing through Host Factor CPSF4.

Authors:  Manuel Rosa-Calatrava; Olivier Terrier; Julia Dubois; Aurélien Traversier; Thomas Julien; Blandine Padey; Bruno Lina; Jean-Christophe Bourdon; Virginie Marcel; Guy Boivin
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

7.  p53 Is a Host Cell Regulator during Herpes Simplex Encephalitis.

Authors:  Yuhei Maruzuru; Naoto Koyanagi; Naoki Takemura; Satoshi Uematsu; Daisuke Matsubara; Yutaka Suzuki; Jun Arii; Akihisa Kato; Yasushi Kawaguchi
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

8.  AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10-mediated regulatory pathway.

Authors:  Roman Hrstka; Pavla Bouchalova; Eva Michalova; Eva Matoulkova; Petr Muller; Philip J Coates; Borivoj Vojtesek
Journal:  Mol Oncol       Date:  2015-12-17       Impact factor: 6.603

9.  Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.

Authors:  Frederico O Gleber-Netto; Mei Zhao; Sanchit Trivedi; Jiping Wang; Samar Jasser; Christina McDowell; Humam Kadara; Jiexin Zhang; Jing Wang; William N William; J Jack Lee; Minh Ly Nguyen; Sara I Pai; Heather M Walline; Dong M Shin; Robert L Ferris; Thomas E Carey; Jeffrey N Myers; Curtis R Pickering
Journal:  Cancer       Date:  2017-10-20       Impact factor: 6.860

Review 10.  Integrated stress response in hepatitis C promotes Nrf2-related chaperone-mediated autophagy: A novel mechanism for host-microbe survival and HCC development in liver cirrhosis.

Authors:  Srikanta Dash; Yucel Aydin; Tong Wu
Journal:  Semin Cell Dev Biol       Date:  2019-08-08       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.